BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32901075)

  • 21. Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.
    Dehn S; Thorp EB
    FASEB J; 2018 Jan; 32(1):254-264. PubMed ID: 28860151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paracrine effect of CXCR4-overexpressing mesenchymal stem cells on ischemic heart injury.
    Wu SZ; Li YL; Huang W; Cai WF; Liang J; Paul C; Jiang L; Wu ZC; Xu M; Zhu P; Wang Y
    Cell Biochem Funct; 2017 Mar; 35(2):113-123. PubMed ID: 28233339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype.
    Hobby ARH; Berretta RM; Eaton DM; Kubo H; Feldsott E; Yang Y; Headrick AL; Koch KA; Rubino M; Kurian J; Khan M; Tan Y; Mohsin S; Gallucci S; McKinsey TA; Houser SR
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H684-H701. PubMed ID: 34415185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.
    Peng Y; Pan W; Ou Y; Xu W; Kaelber S; Borlongan CV; Sun M; Yu G
    Cell Transplant; 2016; 25(5):929-35. PubMed ID: 26498018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
    Cho J; Zhai P; Maejima Y; Sadoshima J
    Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 27. Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats.
    Garikipati VN; Jadhav S; Pal L; Prakash P; Dikshit M; Nityanand S
    PLoS One; 2014; 9(6):e100982. PubMed ID: 24971627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.
    Shin EY; Wang L; Zemskova M; Deppen J; Xu K; Strobel F; García AJ; Tirouvanziam R; Levit RD
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
    Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
    Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100A9 Links Inflammation and Repair in Myocardial Infarction.
    Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
    Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.
    Xie DM; Li YL; Li J; Li Q; Lu G; Zhai Y; Zhang J; Huang Z; Gao X
    Stem Cell Res Ther; 2019 Nov; 10(1):331. PubMed ID: 31747966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac CD68+ and stabilin-1+ macrophages in wound healing following myocardial infarction: From experiment to clinic.
    Ryabov V; Gombozhapova A; Rogovskaya Y; Kzhyshkowska J; Rebenkova M; Karpov R
    Immunobiology; 2018; 223(4-5):413-421. PubMed ID: 29179985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.
    Eghbalzadeh K; Georgi L; Louis T; Zhao H; Keser U; Weber C; Mollenhauer M; Conforti A; Wahlers T; Paunel-Görgülü A
    Front Immunol; 2019; 10():2313. PubMed ID: 31632398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
    Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM
    Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence.
    Wysoczynski M; Guo Y; Moore JB; Muthusamy S; Li Q; Nasr M; Li H; Nong Y; Wu W; Tomlin AA; Zhu X; Hunt G; Gumpert AM; Book MJ; Khan A; Tang XL; Bolli R
    J Am Coll Cardiol; 2017 Apr; 69(14):1824-1838. PubMed ID: 28385312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of VCAM-1 in bone mesenchymal stem cells reduces inflammatory responses and apoptosis to improve cardiac function in rat with myocardial infarction.
    Jiang L; Yang A; Li X; Liu K; Tan J
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108180. PubMed ID: 34607225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac cell therapy: boosting mesenchymal stem cells effects.
    Samper E; Diez-Juan A; Montero JA; Sepúlveda P
    Stem Cell Rev Rep; 2013 Jun; 9(3):266-80. PubMed ID: 22350458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice.
    Toor IS; Rückerl D; Mair I; Thomson A; Rossi AG; Newby DE; Allen JE; Gray GA
    Clin Exp Immunol; 2019 Oct; 198(1):83-93. PubMed ID: 31119724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury.
    Liang H; Hou H; Yi W; Yang G; Gu C; Lau WB; Gao E; Ma X; Lu Z; Wei X; Pei J; Yi D
    Eur Heart J; 2013 Jun; 34(22):1681-90. PubMed ID: 21606086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction.
    Rajasingh J; Bord E; Hamada H; Lambers E; Qin G; Losordo DW; Kishore R
    Circ Res; 2007 Oct; 101(9):910-8. PubMed ID: 17823373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.